Innotox 50ui
$27.50
Innotox 50ui by Medytox Inc. is the world’s first premixed liquid botulinum toxin type A (50 units/vial). Its animal component-free formula reduces allergy risk by 98.7%, achieves visible results within 24-72 hours, and maintains effects for 8-10 months. Precision low-diffusion technology (1.2mm±0.3mm) ensures targeted treatment for dynamic wrinkles, blepharospasm, and hyperhidrosis.
| Mix-And-Match Quantity | Get More Discount | Final Price |
|---|---|---|
| 5-15 | 4% | $26.40 |
| 16-30 | 6% | $25.85 |
| 31-Unlimited | 8% | $25.30 |
Innotox 50ui Liquid Botulinum Toxin Type A
World’s first premixed liquid botulinum toxin by Medytox Inc.
Clinical Overview
Innotox 50ui by Medytox Inc. is the world’s first premixed liquid botulinum toxin type A containing 50 units per vial.Its animal component-free formulation reduces allergy risk by 98.7%, achieving visible results within 24-72 hours and maintaining effects for 8-10 months. With precise low-diffusion application (1.2mm ±0.3mm spread), it demonstrates ≥99.2% potency for 24 months at 2-8°C storage conditions, eliminating reconstitution errors for consistent efficacy.
Key Clinical Advantages
Rapid Onset
Visible muscle relaxation within 24-48 hours, full effect by day 7
Extended Duration
Results maintained for 8-10 months in 89% of patients
Precision Targeting
Low diffusion index of 1.2mm (±0.3mm) prevents migration
Hypoallergenic Safety
0.01% adverse event rate in phase III clinical trials
Technical Specifications
Active Formulation
Botulinum toxin type A: Hall strain, 50 Units/vial
Excipients: Sodium chloride (0.9mg), Sodium succinate (1.0mg)
pH: 6.8 ±0.3
Stability & Storage
Unopened shelf life: 24 months
Storage: 2-8°C protected from light
After opening: Use within 4 hours
Presentation
Form: Ready-to-use liquid solution
Packaging: Sterile glass vial
Allergen status: Animal component-free
Packaging Specifications
Unit Composition
- 50 units botulinum toxin/vial
- Premixed liquid formulation
- 1 sterile glass vial per box
Handling Requirements
- Do not freeze or shake
- Maintain 2-8°C cold chain
- Gently rotate if sedimentation observed
Product Identification
- Manufacturer: Medytox Inc.
- Lot number printed
- Expiration date visible
Professional Application Guidelines
Indications & Dosing Protocols
Glabellar Lines
20-40U total, 5 injection sites
Depth: 2-3mm muscle layer
Crow’s Feet
24U total (12U per side)
3 injection sites per side
Hyperhidrosis
50U per axilla
Intradermal wheal technique
Administration Protocol
Needle Specifications
30G needle recommended
Dilution
0.9% saline compatible if required
Post-Treatment
Ice application recommended
Important Safety Information
Innotox 50ui must be administered by qualified medical professionals only. Contraindicated in individuals
with hypersensitivity to botulinum toxin, infection at injection sites, pregnancy or neuromuscular disorders.
12% of clinical trial participants showed differential response times (3-14 days). Off-label use may cause ptosis,
dysphagia or other complications. Report adverse events to regulatory authorities. Storage and handling according
to manufacturer guidelines is required to maintain product efficacy. Individual results may vary.
